Franz Fazekas, Marieke J.H. Wermer
Abstract
Cerebral amyloid angiopathy (CAA) leads to considerable morbidity and mortality through recurrent lobar intracerebral hemorrhages (ICH). In clinical practice, it is a challenge to identify patients at high risk for a recurrence because of limited clinical and neuroimaging predictors for rebleeding.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cerebral amyloid angiopathy (CAA) leads to considerable morbidity and mortality through recurrent lobar intracerebral hemorrhages (ICH). In clinical practice, it is a challenge to identify patients at high risk for a recurrence because of limited clinical and neuroimaging predictors for rebleeding.
Key concepts: Cerebral amyloid angiopathy, Medicine, Neuroimaging, Angiopathy, Intracerebral hemorrhage, Amyloid (mycology), Intensive care medicine, Clinical Practice